Free Trial
LON:TSTL

Tristel (TSTL) Share Price, News & Analysis

Tristel logo
GBX 392.60 +2.60 (+0.67%)
As of 05/9/2025 12:24 PM Eastern

About Tristel Stock (LON:TSTL)

Key Stats

Today's Range
378
400
50-Day Range
268.30
392.60
52-Week Range
260
572.50
Volume
40,571 shs
Average Volume
107,090 shs
Market Capitalization
£187.55 million
P/E Ratio
28.73
Dividend Yield
3.31%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes. Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries. The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL). For more information about Tristel's product range please visit: https://tristel.com

Receive TSTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tristel and its competitors with MarketBeat's FREE daily newsletter.

TSTL Stock News Headlines

Most traders are panicking. We’re cashing in
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…
See More Headlines

TSTL Stock Analysis - Frequently Asked Questions

Tristel's stock was trading at GBX 421.60 at the beginning of the year. Since then, TSTL stock has decreased by 6.9% and is now trading at GBX 392.60.
View the best growth stocks for 2025 here
.

Tristel plc (LON:TSTL) issued its quarterly earnings data on Monday, February, 24th. The company reported $8.17 EPS for the quarter. Tristel had a trailing twelve-month return on equity of 20.43% and a net margin of 15.47%.

Shares of TSTL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tristel investors own include Standard Life Aberdeen (SL), Barclays (BARC), BP (BP), Capital One Financial (COF), Lloyds Banking Group (LLOY), Automatic Data Processing (ADP) and Ashtead Group (AHT).

Company Calendar

Last Earnings
2/24/2025
Record date for 4/11 Dividend
3/20/2025
Ex-Dividend for 4/11 Dividend
3/20/2025
Dividend Payable
4/11/2025
Today
5/11/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
LON:TSTL
CIK
N/A
Fax
N/A
Employees
208
Year Founded
N/A

Profitability

Trailing P/E Ratio
28.73
Forward P/E Ratio
24.09
P/E Growth
N/A
Net Income
£6.54 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£42.24 million
Cash Flow
GBX 18.73 per share
Price / Cash Flow
20.96
Book Value
GBX 68.34 per share
Price / Book
5.74

Miscellaneous

Free Float
N/A
Market Cap
£187.55 million
Optionable
Not Optionable
Beta
0.23
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (LON:TSTL) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners